Hepatitis B Virus Therapy
Data on hepatitis B virus therapy published by researchers at Chiba University
Published in Hepatitis Weekly, October 29th, 2007
New investigation results, 'Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase,' are detailed in a study published in Journal of Viral Hepatitis. According to recent research from Chiba, Japan, "'This study aimed to identify the viral factors responsible for poor sensitivity to lamivudine (LAM). We analyzed 49 LAM-treated chronic hepatitis B patients infected with hepatitis B virus (HBV) genotype C."
"Serum HBV DNA reached a level below the detection limit of the sensitive PCR assay in 31 (63.3%) within the first 24 weeks of LAM therapy (good responder group). Of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-10-29)
More Articles from Hepatitis Weekly
- Hepatitis
Immune cells fighting chronic infections become progressively 'exhausted,' ineffective - Liver Cancer
Discovery of New Antiviral Mechanism in Mammals May Improve Treatment of Hepatitis C Infections - Hepatitis B Virus
Data from U.H. Iloeje and colleagues advance knowledge in hepatitis B virus - Hepatitis B Virus
Medical Services International Agrees to Retail the VScan Hepatitis B&C Test Kits in SE Asia - Hepatitis B Virus
New hepatitis B virus data have been reported by researchers at Shinshu University, Medical Department - Hepatitis B Virus
New hepatitis B virus study results from I-Shou University described - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
